These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix. Author: Lindgren A, Stendahl U, Brodin T, Lundblad A, Sällström J, Busch C. Journal: Anticancer Res; 1986; 6(2):255-8. PubMed ID: 2423015. Abstract: Immunohistochemical staining of invasive squamous cell carcinoma of the uterine cervix, stage IB to IV, with monoclonal antibodies against blood group antigens shows retained expression of the antigen in two thirds of the patients, regardless of stage. The over-all 5 year survival of the 115 patients was 60%, 71% in the antigen positive group, 37% in the antigen negative group. The loss of blood group antigen expression thus implies a worse prognosis in all stages of cervical carcinoma and could be used as a predictive marker.[Abstract] [Full Text] [Related] [New Search]